Abraha, I. and Chiarolla, E. and Corio, M. and Gillespie, F. and Migliore, A. and Cerbo, M. and Lauvrak, V. and Fagerlund, B.C. and Harboe, I. and Stoinska-Schneider, A. and Wild, C. (2019): Transcatheter aortic valve implantation (TAVI) in patients at intermediate surgical risk. HTA-Projektbericht 115.

Adlbrecht, C. and Radlberger, P. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15/Update2009.

Adlbrecht, C. and Radlberger, P. and Guba, B. and Felder-Puig, R. (2008): [Cardiac contractility modulation for heart failure. Systematic review]. Decision Support Document 15.

Adlbrecht, C. and Radlberger, P. and Reiner-Theisen, I. and Geiger-Gritsch, S. and Mittermayr, T. (2009): Drug coated balloon catheter. Systematic Review. Decision Support Document 24.

Adlbrecht, C. and Radlberger, P. (2010): Cardiac contractility modulation for heart failure. Decision Support Document 15/Update 2010.

Chiarolla, E. and Orso, M. and Götz, G. and Stanak, M. and Wild, C. and Jefferson, T. (2019): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018. Decision Support Document 103/ Update 2018.

Emprechtinger, R. (2018): Echocardiography: Guideline recommendations and options to identify inappropriate use as well as usage rate in Austria. HTA-Projektbericht 98.

Erdos, J. (2022): Percutaneous transvascular implantation of a coronary sinus reducing stent. 1. Update 2022. Decision Support Document 121/ Update 2022.

Ettinger, S. and Stanak, M. and Huić, M. and Hacek, R.T. and Ercevic, D. and Grenkovic, R. and Wild, C. (2016): Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk.. Decision Support Document 103.

Falkner, E. and Wild, C. (2008): Clinical application of Tissue Engineering: An overview of International and Austrian Areas of Research with a critical analysis of selected applications . LBI-HTA Projektbericht 013.

Felder-Puig, R. (2007): [Hypertension and weight-loss. Treatment options]. HTA-Newsletter 54: pp. 2-3.

Felder-Puig, R. (2006): [Coronary surgery, specif. PTCA: Quality and frequencies]. HTA-Newsletter 52: pp. 3-4.

Fischer, S. and Tüchler, H. and Piso, B. (2016): Outpatient cardiac rehabilitation part VII: Economic Evaluation. HTA-Projektbericht 89.

Fischer, S. and Zechmeister-Koss, I. (2014): Costs of day surgery in Austria: An analysis of data and methods for varicose vein surgery as an example. HTA-Projektbericht 71.

Fleischner, B. (2009): Acquisition Processes of Certain Product Groups in Hospitals - Orthopaedic and Cardiac Implants. HTA Projektbericht 38.

Gartlehner, G. and Falkner, E. and Guba, B. and Felder-Puig, R. (2008): [Optical coherence tomography. Systematic review]. Decision Support Document 13.

Gassner, L. and Reinsperger, I. (2021): National strategies and programmes for preventing and managing non-communicable diseases in selected countries. HTA-Projektbericht 139.

Geiger-Gritsch, S. (2008): Stent-graft Implantation for diseases of the ascending aorta. HTA-Newsletter 68: p. 2.

Geiger-Gritsch, S. and Piso, B. and Guba, B. and Felder-Puig, R. (2008): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14.

Geiger-Gritsch, S. (2010): Stent-grafting of the ascending aorta . Decision Support Document 14/Addendum 2010.

Goetz, G. and Walter, M. and Wohlhöfner, K. and Wittenberg, H. and Saal, S. and Stephan, K.M. and Dohle, C. (2021): Robotics and functional electrical stimulation for stroke rehabilitation. HTA-Projektbericht 128.

Goetz, G. and Wernly, B. (2022): Wearable cardioverter-defibrillator (WCD) therapy for primary and secondary prevention of sudden cardiac arrest. Update 2022. Decision Support Document 103/ 2. Update 2022.

Goetz, G. and Schmidt, L. and Erdos, J. and Ciutan, M. and Florescu, S. and Sasu, C. and Scintee, S. G. (2019): POCT/ Point of Care Tests: D-Dimer and Troponin. HTA-Projektbericht 124.

Gottardi, R. and Wild, C. (2011): Percutaneous aortic valve replacement (with a side note on hybrid operating rooms). Decision Support Document 18/Update 2011.

Gyimesi, M. and Piso, B. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3a: Retrospective cohort study (with/without phase III rehabilitation) - explorative analysis and developing of an evaluation plan. HTA-Projektbericht 31a.

Hawlik, K. and Winkler, R. (2018): Baroreceptor activation therapy for treatment-resistant hypertension. Decision Support Document 113.

Hintringer, K. and Warmuth, M. (2013): Percutaneous transluminal coronary angioplasty (PTCA) with paclitaxel-coated drug-eluting balloon (DEB). Update 2013. Decision Support Document 24/ Update 2013.

Huic, M. and Erdos, J. and Wild, C. (2024): Point of Care Tests (POCT): D-Dimer and Troponin. HTA-Projektbericht 124/ 1. Update.

Janatzek, S. and ThomasS, S. and Mad, P. (2010): Percutaneous Repair of mitral regurgitation with the MitraClip . Decision Support Document 41.

Jeindl, R. and Goetz, G. (2021): Percutaneous left ventricular assist devices: micro-axial flow pumps. Decision Support Document 124.

Jeindl, R. and Wernly, B. (2022): His-bundle-pacing for patients requiring a permanent pacemaker or cardiac resynchronisation. Decision Support Document 132.

Johansson, T. and Mathis, S. (2010): Laser angioplasty of coronary arteries . Decision Support Document 39.

Johansson, T. and Wild, C. (2009): Telemedicine in Stroke Management. Systematic Review. HTA-Projektbericht 029.

Kisser, A. and Emprechtinger, R. (2016): Leadless pacemakers for right ventricle pacing. Decision Support Document 97.

Kvas, E. (2006): [Drug eluting stents in comparison to uncoated stents in the treatment of cardiopathy]. Rapid Assessment LBI-HTA 01.

Langer, T. (2006): [Bypass materials in vascular surgery]. HTA-Newsletter 48: pp. 3-4.

Mad, P. (2007): [Telemonitoring for patients with chronic heart failure]. HTA-Newsletter 56: p. 4.

Mad, P. (2007): Drug Eluting Stents (DES): Safety aspects. HTA-Newsletter 53: pp. 2-3.

Mad, P. (2006): [Computed tomographic angiography for coronary artery evaluation]. HTA-Newsletter 48: p. 4.

Mad, P. and Falkner, E. and Guba, B. and Gartlehner, G. (2008): [Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction in patients with congenital heart defects. Systematic review]. Decision Support Document 10.

Mad, P. and Domanovits, H. and Fazelnia, C. and Stiassny, K. (2007): Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction. QJM: An International Journal of Medicine 100 (4): pp. 203-210.

Mathis, S. and Johansson, T. and Mad, P. and Mittermayr, T. (2011): Mechanical percutaneous transluminal cerebral clot retrieval devices in acute ischemic stroke: Systematic Review on efficacy and safety. Decision Support Document 46.

Nachtnebel, A. and Reinsperger, I. (2012): Percutaneous repair of mitral regurgitation with the MitraClip® . Decision Support Document 41 / Update 2012.

Nachtnebel, A. and Warmuth, M. (2013): Percutaneous coronary intervention for chronic total occlusion. Decision Support Document 64.

Patera, N. and Warmuth, M. (2011): Training therapy in physical medicine: Rapid systematic review. Decision Support Document 51.

Piso, B. (2008): Outpatient Cardiac Rehabilitation Part I- Evaluation and Indicators Part II- Comparative analysis of various rehabilitation models and Phase III. HTA-Projektbericht 15.

Piso, B. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Stent-grafting of the ascending aorta. Systematic review]. Decision Support Document 14/Update2009.

Piso, B. and Gyimesi, M. and Tüchler, H. (2010): Outpatient cardiac rehabilitation. Part 3b: Retrospective cohort study (with/without phase III rehabilitation) - application of the evaluation plan. HTA-Projektbericht 31b.

Piso, B. and Tüchler, H. (2016): Outpatient cardiac rehabilitation part VI: prospective multi-centre cohort study (comparing patients with and without phase III). HTA-Projektbericht 90.

Piso, B. and Tüchler, H. (2012): Outpatient cardiac rehabilitation. Part V: Study protocol "Multi-centre, prospective cohort study with two control groups (with/without phase III)". Decision Support Document 50.

Piso, B. and Tüchler, H. (2011): Outpatient cardiac rehabilitation part IV: Options for a prospective study. Decision Support Document 048.

Reichel, M. and Zechmeister-Koss, I. (2012): Renal denervation in patients with essential hypertension . Decision Support Document 45 / Update 2012.

Reinsperger, I. and Nachtnebel, A. (2014): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (1st Update 2014). Decision Support Document 44/ Update 2014.

Reinsperger, I. and Piso, B. (2015): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB) (1st Update 2015). Decision Support Document 68/ 1. Update 2015.

Reinsperger, I. and Piso, B. (2015): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation (2nd Update 2015). Decision Support Document 44/ 2. Update 2015.

Robausch, M. and Emprechtinger, R. (2017): Percutaneous aortic valve replacement (TAVI) in Austria. Part 2: Data analysis. HTA-Projektbericht 95b.

Rothschedl, E. and Nachtnebel, A. (2015): Defibrotide for the treatment and prophylaxis of hepatic veno-occlusive disease. Decision Support Document 84.

Schumacher, I. and Warmuth, M. (2011): Exercise therapy (Krankengymnastik/Heilgymnastik) in physical medicine: Rapid systematic review. Decision Support Document 52.

Scott, A. and Kern, J. and Vreugdenburg, T. (2024): Caval valve implantation (CAVI) for severe tricuspid regurgitation. Decision Support Document 139.

Semlitsch, T. and Krenn, C. (2024): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB) in patients with coronary artery disease (CAD). 3rd Update. Decision Support Document 24/ 3. Update 2024.

Semlitsch, T. and Loder, C. (2023): Percutaneous mitral valve repair with a clip device in patients with mitral regurgitation. 2nd Update 2023. Decision Support Document 41/ Update 2023.

Semlitsch, T. and Zipp, C. and Loder, C. (2022): Percutaneous coronary interventions (PCI) for chronic total occlusion (CTO). Update 2022. Decision Support Document 64/ Update 2022.

Semlitsch, T. and Loder, C. (2020): Leadless pacemaker for right ventricle pacing (Update 2020). Decision Support Document 97/ Update 2020.

Semlitsch, T. and Ciutan, M. and Scintee, S.G. (2019): Bioresorbable stents for the treatment of cardiovascular indications (coronary artery disease). EUnetHTA-Report. Decision Support Document 81/ Update 2019.

Semlitsch, T. and Horvath, K. (2016): Percutaneous transluminal coronary angioplasty (PTCA) with drug-eluting balloon (DEB). 2nd Update 2016 . Decision Support Document 24/ 2. Update 2016.

Semlitsch, T. and Krenn, C. (2018): (Percutaneous) left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation. 3rd Update 2018. Decision Support Document 44/ Update 2018.

Semlitsch, T. and Posch, N. (2017): Leadless pacemakers for right ventricle pacing. Update 2017. Decision Support Document 97/ 1. Update 2017.

Stanak, M. and Rothschedl, E. (2020): Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent. Decision Support Document 121.

Stumpner, T. (2013): Percutaneous transcatheter closure of prosthetic mitral and aortic paravalvular leaks. Decision Support Document 70.

Wagner, G. and Glechner, A. (2018): Subcutaneous implantable cardioverter defibrillator (ICD). Decision Support Document 109.

Walter, M. and Strohmaier, C. (2020): Genetic Testing in the Context of Familial Hypercholesterolaemia Management. HTA-Projektbericht 130.

Warmuth, M. (2013): Endovascular repair of aortic aneurysms. Decision Support Document 69.

Warmuth, M. and Schumacher, I. (2011): Percutaneous left atrial appendage closure for the prevention of thromboembolic events in patients with atrial fibrillation . Decision Support Document 44.

Warmuth, M. and Schumacher, I. and Maringer, B. (2011): Efficacy and safety of treatment options for varicose veins. HTA-Projektbericht 051.

Warmuth, M. and Stumpner, T. (2013): Percutaneous transluminal angioplasty (PTA) of periphery arteries with drug-eluting balloon (DEB). Decision Support Document 68.

Warmuth, M. and Stumpner, T. (2012): Therapeutic hypothermia (TH). Decision Support Document 63.

Wegman, M. and Thomas, S. and Deuber, HJ. (2011): Renal denervation in patients with essential hypertonia. Decision Support Document 45.

Wild, C. (2007): [Drug Eluting Stents (DES). Update February 27th, 2007. HTA in hospitals]. HTA in hospitals. Vienna, 27.02.2007.

Wild, C. (2006): [Carotid stenting for carotid artery stenosis]. HTA-Newsletter 46: p. 4.

Wild, C. (2005): [Statins for acute coronary syndrome]. HTA-Newsletter 42: pp. 3-4.

Wild, C. (2005): [Coronary heart disease. Risk models]. HTA-Newsletter 36: p. 3.

Wild, C. (2005): [Screening for abdominal aortic aneurysm (AAA)]. HTA-Newsletter 36: p. 2.

Wild, C. (2005): [Intraoperative ablation for atrial fibrillation]. HTA-Newsletter 33: p. 2.

Wild, C. (2004): [Drug eluting stents: An economic analysis]. HTA-Newsletter 31: pp. 3-4.

Wild, C. (2004): [Implantable defibrillators/ICD]. HTA-Newsletter 31: p. 2.

Wild, C. (2004): [Sclerotherapy for leg varicose veins]. HTA-Newsletter 30: pp. 2-3.

Wild, C. (2003): [Cardiac resynchronisation therapy (CRT) for heart failure]. HTA-Newsletter 23: pp. 3-4.

Wild, C. (2003): [Graftskin (Apligraf®) in the treatment of venous leg ulcers]. HTA-Newsletter 21: pp. 3-4.

Wild, C. (2003): [Computed tomography in screening for lung cancer]. HTA-Newsletter 21: p. 4.

Wild, C. (2003): [Troponin testing in acute coronary syndromes]. HTA-Newsletter 18: p. 4.

Wild, C. (2003): [Endovascular surgery for abdominal aortic aneurysm/AAA]. HTA-Newsletter 15: p. 4.

Wild, C. (2003): [Implantable cardioverter defibrillator]. HTA-Newsletter 14: p. 4.

Wild, C. (2002): [Glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes]. HTA-Newsletter 13: pp. 2-3.

Wild, C. (2002): [Coated stents]. HTA-Newsletter 13: pp. 3-4.

Wild, C. (2002): [Treatment of varicose veins]. HTA-Newsletter 12: pp. 3-4.

Wild, C. (2002): [Clopidogrel (Plavix): Secondary prevention of coronary heart disease]. HTA-Newsletter 04: p. 2.

Wild, C. and Geiger-Gritsch, S. and Mittermayr, T. (2009): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18/Update2009.

Wild, C. and Langley, T. and Guba, B. and Gartlehner, G. (2008): [Percutaneous aortic valve replacement. Systematic review]. Decision Support Document 18.

Wild, C. (2015): Transcatheter implantable devices for mitral valve repair in adults with chronic mitral valve regurgitation (MitraClip®, Carillon®, NeoChord DS1000). German short version of the correspondent EUnetHTA assessment. Decision Support Document 93.

Wild, C. (2013): Percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophic obstructive cardiomyopathy (HOCM) . Decision Support Document 71.

Wild, C. (2010): Percutaneous aortic valve replacement. Decision Support Document 18/Update 2010.

Wild, C. (2007): [Drug eluting stents. Status quo]. ÖKZ: Österreichische Krankenhauszeitung 48 (03).

Wild, C. and Frank, W. and Huber, K. and Konta, B. (2003): [GP IIb/IIIA inhibitors in the treatment of patients with coronary heart disease]. Köln: DIMDI. ISBN 3-89906-703-7.

Winkler, R. and Wild, C. (2020): Implantation of a wireless pulmonary artery pressure sensor in patients with advanced heart failure. Decision Support Document 119.

Winkler, R. (2015): Transcatheter mitral valve-in-valve implantation. Decision Support Document 82.

Wolf, S. (2022): Long COVID care pathways and structures: an updated scoping review. HTA-Projektbericht 135b/ Update.

Wolf, S. and Erdos, J (2021): Epidemiology of long COVID: a preliminary report. German short version of the original KCE report. HTA-Projektbericht 135a.

Wolf, S. and Erdos, J. (2021): Long COVID care pathways: a systematic review. HTA-Projektbericht 135b.

Wolf, S. and Goetz, G. (2022): Subcutaneous implantable cardioverter-defibrillator (S-ICD). 1. Update 2022: Systematic review. Decision Support Document 109/ Update 2022.

Wolf, S. and Fischer, S. (2017): Transcatheter Aortic Valve Implantation Part I: A systematic review of health economic evaluations. HTA-Projektbericht 95a.

Zechmeister, I. (2006): [Statins: Economic evaluation]. HTA-Newsletter 48: p. 2.

Zechmeister, I. and Stollenwerk, B. and Ara, R. and Ward, S. (2008): Statins for the Secondary Prevention of Cardiovascular Diseases: An Analysis of Expected Population Health Gains and Cost-Utility in Austria (Part II of the project 'Statins: A comparison between predicted and actual effects on population health in Austria') . HTA-Projektbericht 018.

Zechmeister, I. and Stollenwerk, B. and Langley, T. (2008): Have Statins Met Our Expectations? A Comparison of Expected Health Gains from Statins with Epidemiological Trends in Austria (Part III of the Project 'Statins: A Comparison Between Predicted and Actual Effects on Population Health in Austria'). HTA-Projektbericht 019.

Zechmeister, I. and Wild, C. (2006): [Statins and their prognosed as well as real impact on hospital services in Austria]. ITA-Projektbericht 30.

Zechmeister, I. (2006): [Cost-effectiveness of statins]. ITA-Newsletter March 2006: p. 3.

Zechmeister-Koss, I and Fischer, S. (2014): Drug eluting stents for the treatment of peripheral artery disease. Decision Support Document 75.

Zechmeister-Koss, I. and Rothschedl, E. (2015): Fully bioresorbable scaffolds for coronary artery disease. Decision Support Document 81.